Sudeb Dalai MD PhD
HIV/AIDS Medicine, Transplant/Immunocompromised States, International Health, Travel & Tropical
Clinical Assistant Professor, Stanford University | Infectious Disease Physician, Palo Alto Medical Foundation
Join to View Full Profile
795 El Camino Real# LevelPalo Alto, CA 94301
Phone+1 650-723-4000
Dr. Dalai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Infectious Disease, 2015 - 2018
University of California (San Diego) Medical CenterResidency, Internal Medicine, 2013 - 2015- University of California (San Diego) Medical CenterInternship, Internal Medicine, 2013 - 2014
University of California Berkeley, School of Public HealthPhD, Epidemiology, 2008 - 2013
Stanford University School of MedicineClass of 2013, MD- Stanford University School of MedicineMS, Epidemiology, 2008 - 2010
- Massachusetts Institute of TechnologyBS, Brain and Cognitive Sciences, 1998 - 2002
Certifications & Licensure
CA State Medical License 2015 - 2027
MA State Medical License 2024 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
AOA Board of Internal Medicine Internal Medicine
Clinical Trials
- Pneumonia in the ImmunoCompromised - Use of the Karius Test for the Detection of Undiagnosed Pathogens Start of enrollment: 2019 Nov 05
Publications & Presentations
PubMed
- 41 citationsMicrobial Cell-Free DNA Identifies the Causative Pathogen in Infective Endocarditis and Remains Detectable Longer Than Conventional Blood Culture in Patients with Prio...Emily M Eichenberger, Nicholas Degner, Erick R Scott, Felicia Ruffin, John Franzone
Clinical Infectious Diseases. 2023-02-08 - 18 citationsClinical Validation of a Novel T-Cell Receptor Sequencing Assay for Identification of Recent or Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection.Sudeb C Dalai, Jennifer N Dines, Thomas M Snyder, Rachel M Gittelman, Tera Eerkes
Clinical Infectious Diseases. 2022-12-19 - 19 citationsT cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibodies and disease severity.Rebecca Elyanow, Thomas M Snyder, Sudeb C Dalai, Rachel M Gittelman, Jim Boonyaratanakornkit
JCI Insight. 2022-05-23
Press Mentions
Wuhan Study Offers Sobering New Insight into Fatality Rate of CoronavirusMarch 19th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
